Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:midazolam
|
| gptkbp:antidote |
gptkb:flumazenil
|
| gptkbp:approvedBy |
1985
|
| gptkbp:contraindication |
acute narrow-angle glaucoma
hypersensitivity to midazolam |
| gptkbp:controlledSubstanceSchedule |
Schedule IV (US)
|
| gptkbp:drugClass |
benzodiazepine
|
| gptkbp:eliminationHalfLife |
1.5–2.5 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Versed
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous intranasal |
| gptkbp:sideEffect |
gptkb:center
drowsiness hypotension respiratory depression |
| gptkbp:usedFor |
anesthesia induction
procedural sedation sedation seizure control |
| gptkbp:bfsParent |
gptkb:Rae_Armantrout
|
| gptkbp:bfsLayer |
4
|